| EFA | EFAD | EFA / EFAD | |
| Gain YTD | 28.534 | 15.553 | 183% |
| Net Assets | 69.5B | 66.5M | 104,511% |
| Total Expense Ratio | 0.32 | 0.50 | 64% |
| Turnover | 3.00 | 40.00 | 8% |
| Yield | 2.73 | 2.32 | 117% |
| Fund Existence | 24 years | 11 years | - |
| EFA | EFAD | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 75% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 75% |
| Advances ODDS (%) | 3 days ago 83% | 3 days ago 77% |
| Declines ODDS (%) | 24 days ago 79% | 11 days ago 76% |
| BollingerBands ODDS (%) | 1 day ago 90% | N/A |
| Aroon ODDS (%) | 1 day ago 74% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 31.50 | 0.02 | +0.05% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| IGBH | 24.42 | -0.04 | -0.17% |
| iShares Interest Rate Hdg L/T Corp BdETF | |||
| CPSN | 26.74 | -0.06 | -0.21% |
| Calamos S&P 500 Structured Alt Protection ETF - November | |||
| ISCF | 40.51 | -0.37 | -0.91% |
| iShares MSCI Intl Small-Cap Mltfct ETF | |||
| CWB | 89.02 | -2.39 | -2.61% |
| State Street® SPDR® Blmbg Cnvrt Secs ETF | |||
A.I.dvisor indicates that over the last year, EFA has been closely correlated with STM. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if EFA jumps, then STM could also see price increases.
A.I.dvisor tells us that EFAD and BNR have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EFAD and BNR's prices will move in lockstep.
| Ticker / NAME | Correlation To EFAD | 1D Price Change % | ||
|---|---|---|---|---|
| EFAD | 100% | -0.93% | ||
| BNR - EFAD | 14% Poorly correlated | -7.29% | ||
| APA - EFAD | 11% Poorly correlated | +3.35% | ||
| UCB - EFAD | 6% Poorly correlated | -0.50% | ||
| ASML - EFAD | 6% Poorly correlated | -1.68% | ||
| SAN - EFAD | 5% Poorly correlated | -0.91% | ||
More | ||||